GPC1 and breast carcinoma: Breast cancer cells are also shown to overexpress HSPGs, such as Glypican 1 (GPC1) and Syndecan 1 (SDC1), which enhance the proliferative response after treatment with various growth factors due to prolonged signaling (86).